Histopathological Examination of an Explanted Heart in a Long-Term Responder to Cardiac Stereotactic Body Radiotherapy (STereotactic Arrhythmia Radioablation).

Front Cardiovasc Med · 2022 · PMC9302025 · PMID 35872906

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Considering that STAR is an emerging treatment modality, and heart transplants in such patients are exceptionally rare, we believe that our study provides important data, which might be significant for the development of an accurate biological model of the in-human antiarrhythmic effect of STAR.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.